Target intelligence / Profile preview

Raftlin, lipid raft linker 1 pseudogene 1 (RFTN1P1)

Target
RFTN1P1
Molecular classification
Other (Pseudogene; not a protein-coding receptor, enzyme, transporter, etc.)
01

Overview

Raftlin, lipid raft linker 1 pseudogene 1 (RFTN1P1) is a human pseudogene related to the functional Raftlin, lipid raft linker 1 (RFTN1) gene[1][6]. While RFTN1 encodes a lipid raft–associated protein involved in membrane organization, immune receptor signaling (specifically B cell receptor and toll-like receptor signaling), and disease pathology, the RFTN1P1 locus does not produce a functional protein. As such, it is neither a therapeutic target nor associated with disease roles or biomarkers, and is listed mainly as a genomic annotation[1][6]. If you intended to inquire about the functional gene/protein Raftlin, lipid raft linker 1 (RFTN1) (not the pseudogene RFTN1P1), RFTN1 is a lipid raft scaffold protein involved in immune signaling, cell proliferation, and pathological conditions including cancer, chronic inflammation, and glaucoma[2][3][4]. However, the pseudogene RFTN1P1 itself is not a functional molecule or a target in therapeutics[1][6].

Other names
Raft-linking protein pseudogeneRFTN1P1
02

Mechanism of action

Not applicable, as pseudogenes are not active therapeutic targets.

03

Biological functions

None known for RFTN1P1; as a pseudogene, it does not encode a functional protein and does not participate in biological pathways.
04

Disease associations

None known; RFTN1P1 itself is not implicated in disease due to lack of functional expression.
05

Safety considerations

None; RFTN1P1 is not used or targeted in therapy.
06

Interacting drugs

None; no drugs target RFTN1P1.
07

Biomarkers

None for RFTN1P1.

Beyond the preview

Go deeper on Raftlin, lipid raft linker 1 pseudogene 1 (RFTN1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raftlin, lipid raft linker 1 pseudogene 1 (RFTN1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call